| | | |

Predicting Mesothelioma Outcomes with FDG-PET: A New Model

Predicting Mesothelioma Outcomes with FDG-PET

Swiss doctors have created a new tool for predicting mesothelioma outcomes with FDG-PET scans. 

FDG-PET scanning is a nuclear imaging technique. It gives doctors a non-invasive way to track the growth of pleural mesothelioma tumors. 

The Swiss team analyzed multiple PET scans and CT scans from mesothelioma patients. They used a computer to look for commonalities in the scans. Then they used the information to create a computer model for predicting mesothelioma outcomes with FDG-PET.

The model may help doctors and patients make better decisions about mesothelioma treatment in the future. 

Imaging Studies for Mesothelioma Prognosis

Pleural mesothelioma tumors occur on the pleural lining around the lungs. In the early stages, mesothelioma causes few symptoms. As mesothelioma tumors grow, they can impact other organs in the chest. If a doctor suspects mesothelioma, he or she may order an imaging scan.

Imaging studies like CT and FDG-PET help doctors diagnose and predict mesothelioma outcomes. These tools make it possible to look inside the chest without making incisions. They provide information about the size and location of tumors which can impact mesothelioma prognosis.

CT scans take X-rays from different angles. The X-rays get compiled into a single 3D image. Predicting mesothelioma outcomes with FDG-PET relies on a tracer. Cancer cells absorb more of the FDG tracer so they show up brighter on the PET image. 

But these scans can be tricky to read. Unless a doctor is very experienced at predicting mesothelioma outcomes with FDG-PET or CT, they may miss some signs of mesothelioma.

A Better Tool for Predicting Mesothelioma Outcomes with FDG-PET?

Machine learning is a way of teaching computers to find patterns in data. The Swiss team hoped it could improve accuracy in reading PET and CT scans for mesothelioma prognosis. 

They collected imaging scans from 72 mesothelioma patients. The patients had surgery at their hospital between 2009 and 2017. 

A computer program analyzed the mesothelioma imaging scans. It identified more than 1,400 features from each image. The team picked out the features that were most closely linked to mesothelioma prognosis. They used these features to “teach” the computer to predict mesothelioma outcomes. This modeling is called radiomics. 

The computer could not create an accurate radiomics model from the CT data. But the FDG-PET images worked better. The computer model made from these images proved to be an accurate way of predicting mesothelioma outcomes with FDG-PET. 

“We were able to build a successful FDG-PET radiomics model for the prediction of progression free survival in malignant pleural mesothelioma,” say the Swiss researchers. “Radiomics could serve as a tool to aid clinical decision support systems for treatment of malignant pleural mesothelioma in future.”

Source: 

Pavic, M, et al, “FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients”, July 13, 2020, EJNMMI Research, https://ejnmmires.springeropen.com/articles/10.1186/s13550-020-00669-3

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…